{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T10:55:44Z","timestamp":1791111344438,"version":"4.1.0"},"reference-count":48,"publisher":"Japanese Society for the Study of Xenobiotics","issue":"4","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[2012]]},"DOI":"10.2133\/dmpk.dmpk-11-rg-078","type":"journal-article","created":{"date-parts":[[2012,1,24]],"date-time":"2012-01-24T05:20:35Z","timestamp":1327382435000},"page":"405-413","source":"Crossref","is-referenced-by-count":27,"title":["Inter-individual Variability of In Vivo CYP2D6 Activity in Different Genotypes"],"prefix":"10.2133","volume":"27","author":[{"given":"Koji","family":"Chiba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motohiro","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Suwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"900","reference":[{"key":"10.2133\/dmpk.DMPK-11-RG-078_bb0005","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2174\/138920007779315053","article-title":"Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human microsomal protein and hepato- cellularity per gram of liver","volume":"8","author":"Barter","year":"2007","journal-title":"Curr. Drug Metab."},{"key":"10.2133\/dmpk.DMPK-11-RG-078_bb0010","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1517\/17425250802691074","article-title":"The Simcyp population-based ADME simulator","volume":"5","author":"Jamei","year":"2009","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.2133\/dmpk.DMPK-11-RG-078_bb0015","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2133\/dmpk.DMPK-09-RG-038","article-title":"Prediction of interindividual variability in pharmacokinetics for CYP3A4 substrates in humans","volume":"25","author":"Kato","year":"2010","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.2133\/dmpk.DMPK-11-RG-078_bb0020","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2133\/dmpk.25.243","article-title":"Estimation of the interindividual variability of cytochrome 2D6 activity from urinary metabolic ratios in the literature","volume":"25","author":"Ito","year":"2010","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.2133\/dmpk.DMPK-11-RG-078_bb0025","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1124\/dmd.107.015354","article-title":"Comparative metabolic capabilities and inhibitory profiles of CYP2D6.1, CYP2D6.10, and CYP2D6.17","volume":"35","author":"Shen","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.2133\/dmpk.DMPK-11-RG-078_bb0030","doi-asserted-by":"crossref","first-page":"689","DOI":"10.2165\/11318030-000000000-00000","article-title":"Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I","volume":"48","author":"Zhou","year":"2009","journal-title":"Clin. Pharmacokinet."},{"key":"10.2133\/dmpk.DMPK-11-RG-078_bb0035","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2217\/14622416.10.1.17","article-title":"Pharmacogenetics of debrisoquine and its use as a marker for CYP2D6 hydroxylation capacity","volume":"10","author":"Llerena","year":"2009","journal-title":"Pharmacogenomics"},{"key":"10.2133\/dmpk.DMPK-11-RG-078_bb0040","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00228-006-0250-8","article-title":"Evaluation of probe drugs and pharmacokinetic metrics for CYP2D6 phenotyping","volume":"63","author":"Frank","year":"2007","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.2133\/dmpk.DMPK-11-RG-078_bb0045","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/sj.clpt.6100482","article-title":"Pharmacokinetics\/genotype associations for major cytochrome P450 enzymes in native and first- and third-generation Japanese populations: comparison with Korean, Chinese, and Caucasian populations","volume":"84","author":"Myrand","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.2133\/dmpk.DMPK-11-RG-078_bb0050","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.2042-7158.1986.tb04540.x","article-title":"Correlation between in-vitro microsomal enzyme activity and whole organ hepatic elimination kinetics: analysis with a dispersion model","volume":"38","author":"Roberts","year":"1986","journal-title":"J. Pharm. Pharmacol."},{"key":"10.2133\/dmpk.DMPK-11-RG-078_bb0055","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1124\/dmd.31.5.580","article-title":"Utility of hepatocytes in predicting drug metabolism: comparison of hepatic intrinsic clearance in rats and humans in vivo and in vitro","volume":"31","author":"Naritomi","year":"2003","journal-title":"Drug Metab. Dispos."},{"key":"10.2133\/dmpk.DMPK-11-RG-078_bb0060","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2133\/dmpk.23.328","article-title":"A novel approach to the prediction of drug-drug interactions in humans based on the serum incubation method","volume":"23","author":"Shibata","year":"2008","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.2133\/dmpk.DMPK-11-RG-078_bb0065","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00004714-199508000-00005","article-title":"Pharmacokinetics of dextromethorphan and metabolites in humans: influence of the CYP2D6 phenotype and quinidine inhibition","volume":"15","author":"Schadel","year":"1995","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.2133\/dmpk.DMPK-11-RG-078_bb0070","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hep.1840090222","article-title":"The effect of age upon liver volume and apparent liver blood flow in healthy man","volume":"9","author":"Wynne","year":"1989","journal-title":"Hepatology"},{"key":"10.2133\/dmpk.DMPK-11-RG-078_bb0075","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/(SICI)1099-081X(199607)17:5<421::AID-BDD421>3.0.CO;2-9","article-title":"Pharmaco- kinetics and polymorphic oxidation of dextromethorphan in a Japanese population","volume":"17","author":"Nagai","year":"1996","journal-title":"Biopharm. Drug Dispos."},{"key":"10.2133\/dmpk.DMPK-11-RG-078_bb0080","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/sj.clpt.6100406","article-title":"The CYP2D6 activity score: translating genotype information into a qualitative measure of phenotype","volume":"83","author":"Gaedigk","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.2133\/dmpk.DMPK-11-RG-078_bb0085","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0022-3565(24)37524-X","article-title":"Novel single-point plasma or saliva dextromethorphan method for determining CYP2D6 activity","volume":"285","author":"Hu","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.2133\/dmpk.DMPK-11-RG-078_bb0090","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/01.fpc.0000239974.69464.f2","article-title":"CYP2D6 worldwide genetic variation shows high frequency of altered activity variants and no continental structure","volume":"17","author":"Sistonen","year":"2007","journal-title":"Pharmacogenet. Genomics"},{"key":"10.2133\/dmpk.DMPK-11-RG-078_bb0095","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/00008571-200110000-00004","article-title":"Comprehensive analysis of the genetic factors determining expression and function of hepatic CYP2D6","volume":"11","author":"Zanger","year":"2001","journal-title":"Pharmacogenetics"},{"key":"10.2133\/dmpk.DMPK-11-RG-078_bb0100","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/00008571-199912000-00005","article-title":"Decreased capacity for debrisoquine metabolism among black Tanzanians: analyses of the CYP2D6 genotype and phenotype","volume":"9","author":"Wennerholm","year":"1999","journal-title":"Pharmacogenetics"},{"key":"10.2133\/dmpk.DMPK-11-RG-078_bb0105","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.pain.2009.03.023","article-title":"Can extremely low or high morphine formation from codeine be predicted prior to therapy initiation?","volume":"144","author":"Lotsch","year":"2009","journal-title":"Pain"},{"key":"10.2133\/dmpk.DMPK-11-RG-078_bb0110","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1023\/A:1015835215945","article-title":"Phenotypic differences in dextromethorphan metabolism","volume":"6","author":"Vetticaden","year":"1989","journal-title":"Pharm. Res."},{"key":"10.2133\/dmpk.DMPK-11-RG-078_bb0115","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/BF02256117","article-title":"Analysis of pharmacokinetic parameters for assessment of dextromethorphan metabolic phenotypes","volume":"10","author":"Yeh","year":"2003","journal-title":"J. Biomed. Sci."},{"key":"10.2133\/dmpk.DMPK-11-RG-078_bb0120","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1177\/0091270007304103","article-title":"Effect of cinacalcet hydrochloride, a new calcimimetic agent, on the phar- macokinetics of dextromethorphan: in vitro and clinical studies","volume":"47","author":"Nakashima","year":"2007","journal-title":"J. Clin. Pharmacol."},{"key":"10.2133\/dmpk.DMPK-11-RG-078_bb0125","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1124\/dmd.110.033407","article-title":"Effect of the CYP2D6*10 genotype on tolterodine pharmacokinetics","volume":"38","author":"Oishi","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"10.2133\/dmpk.DMPK-11-RG-078_bb0130","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1080\/10937400903158342","article-title":"Genetic polymorphism in cytochrome P450 2D6 (CYP2D6): Population distribution of CYP2D6 activity","volume":"12","author":"Neafsey","year":"2009","journal-title":"J. Toxicol. Environ. Health B Crit. Rev."},{"key":"10.2133\/dmpk.DMPK-11-RG-078_bb0135","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1124\/dmd.105.008920","article-title":"3,4-Dehydrodebrisoquine, a novel debrisoquine metabolite formed from 4-hydroxydebrisoquine that affects the CYP2D6 metabolic ratio","volume":"34","author":"Zhen","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.2133\/dmpk.DMPK-11-RG-078_bb0140","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.pharmthera.2007.09.004","article-title":"Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmaco- epigenetic and clinical aspects","volume":"116","author":"Ingelman-Sundberg","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.2133\/dmpk.DMPK-11-RG-078_bb0145","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1124\/dmd.108.022368","article-title":"Discovery of novel functional variants and extensive evaluation of CYP2D6 genetic polymorphisms in Koreans","volume":"37","author":"Lee","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.2133\/dmpk.DMPK-11-RG-078_bb0150","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/0091270006294279","article-title":"Incorporating in vitro information on drug metabolism into clinical trial simulations to assess the effect of CYP2D6 polymorphism on pharmacokinetics and pharmacodynamics: dextromethorphan as a model application","volume":"47","author":"Dickinson","year":"2007","journal-title":"J. Clin. Pharmacol."},{"key":"10.2133\/dmpk.DMPK-11-RG-078_bb0155","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/S0278-6915(02)00117-5","article-title":"Human variability in polymorphic CYP2D6 metabolism: is the kinetic default uncertainty factor adequate?","volume":"40","author":"Dorne","year":"2002","journal-title":"Food Chem. Toxicol."},{"key":"10.2133\/dmpk.DMPK-11-RG-078_bb0160","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.cccn.2004.03.002","article-title":"Metabolic activity of dextromethorphan O-demethylation in healthy Japanese volunteers carrying duplicated CYP2D6 genes: duplicated allele of CYP2D6*10 does not increase CYP2D6 metabolic activity","volume":"344","author":"Ishiguro","year":"2004","journal-title":"Clin. Chim. Acta"},{"key":"10.2133\/dmpk.DMPK-11-RG-078_bb0165","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0009-9236(99)70077-9","article-title":"Analysis of the CYP2D6 gene in relation to dextromethorphan O-demethylation capacity in a Japanese population","volume":"65","author":"Tateishi","year":"1999","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.2133\/dmpk.DMPK-11-RG-078_bb0170","first-page":"253","article-title":"CYP2D6 genotype and phenotype relationship in South Indians","volume":"52","author":"Naveen","year":"2006","journal-title":"J. Postgrad. Med."},{"key":"10.2133\/dmpk.DMPK-11-RG-078_bb0175","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1365-2125.2000.00209.x","article-title":"Frequencies of CYP2D6 mutant alleles in a normal Japanese population and metabolic activity of dextromethorphan O- demethylation in different CYP2D6 genotypes","volume":"50","author":"Kubota","year":"2000","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.2133\/dmpk.DMPK-11-RG-078_bb0180","first-page":"284","article-title":"Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences","volume":"60","author":"Sachse","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"10.2133\/dmpk.DMPK-11-RG-078_bb0185","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/sj.clpt.6100015","article-title":"Frequency of CYP2D6*10 and *14 alleles and their influence on the metabolic activity of CYP2D6 in a healthy Chinese population","volume":"81","author":"Cai","year":"2007","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.2133\/dmpk.DMPK-11-RG-078_bb0190","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1177\/00912700122010113","article-title":"Food increases the bioavailability of tolterodine but not effective exposure","volume":"41","author":"Olsson","year":"2001","journal-title":"J. Clin. Pharmacol."},{"key":"10.2133\/dmpk.DMPK-11-RG-078_bb0195","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1067\/mcp.2003.25","article-title":"Effect of hepatic impairment on the pharmacokinetics of atomoxetine and its metabolites","volume":"73","author":"Chalon","year":"2003","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.2133\/dmpk.DMPK-11-RG-078_bb0200","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1177\/009127002762491307","article-title":"Effect of potent CYP2D6 inhibition by paroxetine on atomoxetine pharmacokinetics","volume":"42","author":"Belle","year":"2002","journal-title":"J. Clin. Pharmacol."},{"key":"10.2133\/dmpk.DMPK-11-RG-078_bb0205","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1124\/jpet.103.058727","article-title":"Atomoxetine hydrochloride: clinical drug-drug interaction prediction and outcome","volume":"308","author":"Sauer","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.2133\/dmpk.DMPK-11-RG-078_bb0210","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.clpt.2005.03.009","article-title":"Effect of verapamil on pharmacokinetics and pharmaco- dynamics of risperidone: in vivo evidence of involvement of P- glycoprotein in risperidone disposition","volume":"78","author":"Nakagami","year":"2005","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.2133\/dmpk.DMPK-11-RG-078_bb0215","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0009-9236(98)90104-7","article-title":"Influence of CYP2D6 polymorphism on the pharmacokinetics and pharmacodynamic of tolterodine","volume":"63","author":"Brynne","year":"1998","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.2133\/dmpk.DMPK-11-RG-078_bb0220","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/clpt.1993.146","article-title":"Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjects","volume":"54","author":"Huang","year":"1993","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.2133\/dmpk.DMPK-11-RG-078_bb0225","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/01213011-199912000-00004","article-title":"Disposition of debrisoquine in Caucasians with different CYP2D6-genotypes including those with multiple genes","volume":"9","author":"Dalen","year":"1999","journal-title":"Pharmacogenetics"},{"key":"10.2133\/dmpk.DMPK-11-RG-078_bb0230","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0009-9236(98)90069-8","article-title":"Pharmacokinetics of nortriptyline and its 10-hydroxy metabolite in Chinese subjects of different CYP2D6 genotypes","volume":"64","author":"Yue","year":"1998","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.2133\/dmpk.DMPK-11-RG-078_bb0235","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00228-003-0656-5","article-title":"Impact of CYP2D6*10 on mexiletine pharmacokinetics in healthy adult volunteers","volume":"59","author":"Otani","year":"2003","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.2133\/dmpk.DMPK-11-RG-078_bb0240","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s002280100284","article-title":"Duplication of CYP2D6 predicts high clearance of desipramine but high clearance does not predict duplication of CYP2D6","volume":"57","author":"Bergmann","year":"2001","journal-title":"Eur. J. Clin. Pharmacol."}],"container-title":["Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1347436715305061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1347436715305061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T05:25:16Z","timestamp":1742361916000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347436715305061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012]]}},"alternative-id":["S1347436715305061"],"URL":"https:\/\/doi.org\/10.2133\/dmpk.dmpk-11-rg-078","relation":{},"ISSN":["1347-4367"],"issn-type":[{"value":"1347-4367","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]}}}